相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Melatonin mediates mucosal immune cells, microbial metabolism, and rhythm crosstalk: A therapeutic target to reduce intestinal inflammation
Ning Ma et al.
MEDICINAL RESEARCH REVIEWS (2020)
Hormone of darkness and human reproductive process: direct regulatory role of melatonin in human corpus luteum
E. Scarinci et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2019)
Daytime melatonin and light independently affect human alertness and body temperature
Renske Lok et al.
JOURNAL OF PINEAL RESEARCH (2019)
The Mystery behind the Pineal Gland: Melatonin Affects the Metabolism of Cholesterol
Kamil Karolczak et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Synthesis, Bioapplications, and Toxicity Evaluation of Chitosan-Based Nanoparticles
Balsam R. Rizeq et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Light at night disrupts diel patterns of cytokine gene expression and endocrine profiles in zebra finch (Taeniopygia guttata)
Ila Mishra et al.
SCIENTIFIC REPORTS (2019)
Circadian modulation of neuroplasticity by melatonin: a target in the treatment of depression
Marcela Valdes-Tovar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Chitooligosaccharides and their biological activities: A comprehensive review
Fakhra Liaqat et al.
CARBOHYDRATE POLYMERS (2018)
Abnormal Hippocampal Melatoninergic System: A Potential Link between Absence Epilepsy and Depression-Like Behavior in WAG/Rij Rats?
Slavianka Moyanova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The neuroprotective role of melatonin in neurological disorders
B. S. Alghamdi
JOURNAL OF NEUROSCIENCE RESEARCH (2018)
Neuroprotective effect of melatonin against lipopolysaccharide-induced depressive-like behavior in mice
E. H. Taniguti et al.
PHYSIOLOGY & BEHAVIOR (2018)
The effect of polymer length on the in vitro characteristics of a drug loaded and targeted silica nanoparticles
Areen M. Khattabi et al.
SAUDI PHARMACEUTICAL JOURNAL (2018)
PLGA Nanoparticles and Polysorbate-80-coated PLGA Nanoparficles Increase the in vitro Antioxidant Activity of Melatonin
Leiziani Gnatkowski Martins et al.
CURRENT DRUG DELIVERY (2018)
Clinical cosmeceutical repurposing of melatonin in androgenic alopecia using nanostructured lipid carriers prepared with antioxidant oils
Shymaa Hatem et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Melatonin-loaded silica coated with hydroxypropyl methylcellulose phthalate for enhanced oral bioavailability: Preparation, and in vitro-in vivo evaluation
Yuanyuan Li et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Role of the MT1 and MT2 melatonin receptors in mediating depressive- and anxiety-like behaviors in C3H/HeN mice
J. Liu et al.
GENES BRAIN AND BEHAVIOR (2017)
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery
Munawar A. Mohammed et al.
PHARMACEUTICS (2017)
Intranasal melatonin nanoniosomes: pharmacokinetic, pharmacodynamics and toxicity studies
Aroonsri Priprem et al.
THERAPEUTIC DELIVERY (2017)
Characteristics of 4-Day Infradian Biorhythms in Mature Male Wistar Rats after Pinealectomy
M. E. Diatroptov et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2017)
Melatonin releasing PLGA micro/nanoparticles and their effect on osteosarcoma cells
Damla Cetin Altindal et al.
JOURNAL OF MICROENCAPSULATION (2016)
Polylactic acid (PLA) controlled delivery carriers for biomedical applications
Betty Tyler et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Physical and mechanical properties of PLA, and their functions in widespread applications - A comprehensive review
Shady Farah et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Nanoparticle-mediated interplay of chitosan and melatonin for improved wound epithelialisation
Filip Blazevic et al.
CARBOHYDRATE POLYMERS (2016)
Differential melatonin alterations in cerebrospinal fluid and serum of patients with major depressive disorder and bipolar disorder
J. M. Bumb et al.
COMPREHENSIVE PSYCHIATRY (2016)
Antioxidant effect of immediate- versus sustained-release melatonin in type 2 diabetes mellitus and healthy controls
Joanna Rybka et al.
DRUG DELIVERY (2016)
Sustained-Release, Extended-Release, and Other Time-Release Formulations in Neuropsychiatry
Chittaranjan Andrade
JOURNAL OF CLINICAL PSYCHIATRY (2015)
The consumption of a Jerte Valley cherry product in humans enhances mood, and increases 5-hydroxyindoleacetic acid but reduces cortisol levels in urine
Maria Garrido et al.
EXPERIMENTAL GERONTOLOGY (2012)
An exploratory study of combination buspirone and melatonin SR in Major Depressive Disorder (MDD): A possible role for neurogenesis in drug discovery
Maurizio Fava et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2012)
A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood
Marc Antony Serfaty et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
Antidepressant-like effects of melatonin in the mouse chronic mild stress model
Bernardo C. Detanico et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Engineering biodegradable polyester particles with specific drug targeting and drug release properties
Farahidah Mohamed et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: Colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone
Ying-Hui Wu et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2006)
Clinical efficacy of agomelatine in depression: the evidence
JA Den Boer et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2006)
Melatonin exerts an antidepressant-like effect in the tail suspension test in mice:: evidence for involvement of N-methyl-D-aspartate receptors and the L-arginine-nitric oxide pathway
M Mantovani et al.
NEUROSCIENCE LETTERS (2003)
Therapeutic perspectives for melatonin agonists and antagonists
P Delagrange et al.
JOURNAL OF NEUROENDOCRINOLOGY (2003)
Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation
V Raghavendra et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2000)
The absolute bioavailability of oral melatonin
RL DeMuro et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2000)
分享论文
